BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 22869581)

  • 1. Pharmacokinetics and pharmacodynamics of oral artesunate monotherapy in patients with uncomplicated Plasmodium falciparum malaria in western Cambodia.
    Saunders D; Khemawoot P; Vanachayangkul P; Siripokasupkul R; Bethell D; Tyner S; Se Y; Rutvisuttinunt W; Sriwichai S; Chanthap L; Lin J; Timmermans A; Socheat D; Ringwald P; Noedl H; Smith B; Fukuda M; Teja-Isavadharm P
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5484-93. PubMed ID: 22869581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of high-dose or split-dose artesunate on parasite clearance in artemisinin-resistant falciparum malaria.
    Das D; Tripura R; Phyo AP; Lwin KM; Tarning J; Lee SJ; Hanpithakpong W; Stepniewska K; Menard D; Ringwald P; Silamut K; Imwong M; Chotivanich K; Yi P; Day NP; Lindegardh N; Socheat D; Nguon C; White NJ; Nosten F; Dondorp AM
    Clin Infect Dis; 2013 Mar; 56(5):e48-58. PubMed ID: 23175556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artemisinin resistance in Plasmodium falciparum malaria.
    Dondorp AM; Nosten F; Yi P; Das D; Phyo AP; Tarning J; Lwin KM; Ariey F; Hanpithakpong W; Lee SJ; Ringwald P; Silamut K; Imwong M; Chotivanich K; Lim P; Herdman T; An SS; Yeung S; Singhasivanon P; Day NP; Lindegardh N; Socheat D; White NJ
    N Engl J Med; 2009 Jul; 361(5):455-67. PubMed ID: 19641202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artemisinin resistance in Cambodia: a clinical trial designed to address an emerging problem in Southeast Asia.
    Noedl H; Se Y; Sriwichai S; Schaecher K; Teja-Isavadharm P; Smith B; Rutvisuttinunt W; Bethell D; Surasri S; Fukuda MM; Socheat D; Chan Thap L
    Clin Infect Dis; 2010 Dec; 51(11):e82-9. PubMed ID: 21028985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring for Plasmodium falciparum drug resistance to artemisinin and artesunate in Binh Phuoc Province, Vietnam: 1998-2009.
    Thanh NV; Toan TQ; Cowman AF; Casey GJ; Phuc BQ; Tien NT; Hung NM; Biggs BA
    Malar J; 2010 Jun; 9():181. PubMed ID: 20573274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrahost modeling of artemisinin resistance in Plasmodium falciparum.
    Saralamba S; Pan-Ngum W; Maude RJ; Lee SJ; Tarning J; Lindegårdh N; Chotivanich K; Nosten F; Day NP; Socheat D; White NJ; Dondorp AM; White LJ
    Proc Natl Acad Sci U S A; 2011 Jan; 108(1):397-402. PubMed ID: 21173254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced susceptibility of Plasmodium falciparum to artesunate in southern Myanmar.
    Kyaw MP; Nyunt MH; Chit K; Aye MM; Aye KH; Aye MM; Lindegardh N; Tarning J; Imwong M; Jacob CG; Rasmussen C; Perin J; Ringwald P; Nyunt MM
    PLoS One; 2013; 8(3):e57689. PubMed ID: 23520478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetic and pharmacodynamic properties of artesunate in patients with artemisinin sensitive and resistant infections in Southern Myanmar.
    Lohy Das JP; Kyaw MP; Nyunt MH; Chit K; Aye KH; Aye MM; Karlsson MO; Bergstrand M; Tarning J
    Malar J; 2018 Mar; 17(1):126. PubMed ID: 29566683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia.
    Rogers WO; Sem R; Tero T; Chim P; Lim P; Muth S; Socheat D; Ariey F; Wongsrichanalai C
    Malar J; 2009 Jan; 8():10. PubMed ID: 19138388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mefloquine pharmacokinetics and mefloquine-artesunate effectiveness in Peruvian patients with uncomplicated Plasmodium falciparum malaria.
    Gutman J; Green M; Durand S; Rojas OV; Ganguly B; Quezada WM; Utz GC; Slutsker L; Ruebush TK; Bacon DJ
    Malar J; 2009 Apr; 8():58. PubMed ID: 19358697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artemisinin resistance containment project in Thailand. II: Responses to mefloquine-artesunate combination therapy among falciparum malaria patients in provinces bordering Cambodia.
    Satimai W; Sudathip P; Vijaykadga S; Khamsiriwatchara A; Sawang S; Potithavoranan T; Sangvichean A; Delacollette C; Singhasivanon P; Kaewkungwal J; Lawpoolsri S
    Malar J; 2012 Aug; 11():300. PubMed ID: 22929621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study.
    Amaratunga C; Sreng S; Suon S; Phelps ES; Stepniewska K; Lim P; Zhou C; Mao S; Anderson JM; Lindegardh N; Jiang H; Song J; Su XZ; White NJ; Dondorp AM; Anderson TJ; Fay MP; Mu J; Duong S; Fairhurst RM
    Lancet Infect Dis; 2012 Nov; 12(11):851-8. PubMed ID: 22940027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of oral and intravenous artesunate in male Tanzanian adults with Plasmodium falciparum malaria and in vitro susceptibility to artemisinin, chloroquine, and mefloquine.
    Alin MH; Kihamia CM; Bjorkman A; Bwijo BA; Premji Z; Mtey GJ; Ashton M
    Am J Trop Med Hyg; 1995 Dec; 53(6):639-45. PubMed ID: 8561267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Declining in efficacy of a three-day combination regimen of mefloquine-artesunate in a multi-drug resistance area along the Thai-Myanmar border.
    Na-Bangchang K; Ruengweerayut R; Mahamad P; Ruengweerayut K; Chaijaroenkul W
    Malar J; 2010 Oct; 9():273. PubMed ID: 20929590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring antimalarial drug efficacy in the Greater Mekong Subregion: an overview of in vivo results from 2008 to 2010.
    Bustos MD; Wongsrichanalai C; Delacollette C; Burkholder B
    Southeast Asian J Trop Med Public Health; 2013; 44 Suppl 1():201-30; discussion 306-7. PubMed ID: 24159833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artesunate dose escalation for the treatment of uncomplicated malaria in a region of reported artemisinin resistance: a randomized clinical trial.
    Bethell D; Se Y; Lon C; Tyner S; Saunders D; Sriwichai S; Darapiseth S; Teja-Isavadharm P; Khemawoot P; Schaecher K; Ruttvisutinunt W; Lin J; Kuntawungin W; Gosi P; Timmermans A; Smith B; Socheat D; Fukuda MM
    PLoS One; 2011; 6(5):e19283. PubMed ID: 21603629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining the in vivo phenotype of artemisinin-resistant falciparum malaria: a modelling approach.
    White LJ; Flegg JA; Phyo AP; Wiladpai-ngern JH; Bethell D; Plowe C; Anderson T; Nkhoma S; Nair S; Tripura R; Stepniewska K; Pan-Ngum W; Silamut K; Cooper BS; Lubell Y; Ashley EA; Nguon C; Nosten F; White NJ; Dondorp AM
    PLoS Med; 2015 Apr; 12(4):e1001823. PubMed ID: 25919029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetics of mefloquine given as a 3-day artesunate-mefloquine in patients with acute uncomplicated Plasmodium falciparum malaria in a multidrug-resistant area along the Thai-Myanmar border.
    Hoglund RM; Ruengweerayut R; Na-Bangchang K
    Malar J; 2018 Sep; 17(1):322. PubMed ID: 30176888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gametocyte clearance dynamics following oral artesunate treatment of uncomplicated falciparum malaria in Malian children.
    Djimde AA; Maiga AW; Ouologuem D; Fofana B; Sagara I; Dembele D; Toure S; Sanogo K; Dama S; Sidibe B; Doumbo OK
    Parasite; 2016; 23():3. PubMed ID: 26839003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How Robust Are Malaria Parasite Clearance Rates as Indicators of Drug Effectiveness and Resistance?
    Hastings IM; Kay K; Hodel EM
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6428-36. PubMed ID: 26239987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.